ArticleInternational journal of oncology2018

Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma.

Weijie Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.